https://idataresearch.com/wp-content/themes/lambda-child-theme/images/footer-logo.png
https://idataresearch.com/wp-content/themes/lambda-child-theme/images/idata-white-logo.png

Clot Management

Showing 1–16 of 20 results

Peripheral Vascular Procedure Volume Analysis | Global | 2021-2026 | MedPro | Segmented by: Material, Indication, Type, and More

Globally, over 16 million peripheral vascular procedures were performed in 2020. The majority of these procedures were vascular closure device procedures followed by PTA balloon catheter procedures.

more...

Peripheral Vascular Devices Market Analysis, Size, Trends | Global | 2020-2026 | MedSuite

In 2020, the global peripheral vascular device market size was valued at $11.9 billion, with over 16 million yearly peripheral vascular procedures performed. The market size is expected to increase at a compound annual growth rate (CAGR) of 5.2% to reach $16.9 billion in 2026. Throughout this medical market research, we analyzed 113 peripheral vascular

more...

Peripheral Vascular Devices Market Analysis, Size, Trends | Europe | 2020-2026 | MedSuite

In 2020, the European peripheral vascular device market size was valued at about €1.3 billion, with over 1.15 million peripheral vascular procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 2.9% to reach €1.6 billion in 2026. Throughout this medical market research, we analyzed 65

more...

Peripheral Vascular Devices Market Analysis, Size, Trends | United States | 2020-2026 | MedSuite

In 2020, the U.S. peripheral vascular device market size was valued at $7.1 billion, with over 8.26 million peripheral vascular procedures performed each year. The market size is expected to increase and reach $10.4 billion by 2026. Throughout this medical market research, we analyzed 67 peripheral vascular companies across the United States and used our comprehensive

more...

Stent Graft Market Size, Share & Trends Analysis | Global | 2020-2026 | MedCore | Includes: Surgical Grafts (Lower Limb, Aorta Repair, Extra-Anatomical Bypass Surgical Grafts) & Stent Grafts (AAA, TAA, FAA Stent Grafts)

The global stent graft market size is expected to reach over $4.8 billion by 2026, while the surgical graft market size is projected to exceed $117 million. Currently, the majority of the global stent market share is controlled by Medtronic and W.L.Gore. AAA stent grafts continued to comprise the largest segment of the stent grafts

more...

Thrombus Management Market Analysis | United States | 2020-2026 | MedCore

Thrombosis is defined as the formation of a blood clot inside a blood vessel, which obstructs the flow of blood. Thrombus can become life threatening if it dislodges from the vessel wall and enters the lungs or other vital organ. A fragment of thrombus traveling through the vascular system is called an embolus.

more...

Peripheral Vascular Stent Market Analysis | United States | 2020-2026 | MedCore

Stents are commonly used as complementary devices during conventional percutaneous transluminal angioplasty (PTA) balloon catheterization in peripheral vascular procedures. The placement of a stent mitigates some complications, such as negative remodeling and elastic recoil effects.

more...

PTA Balloon Catheter & Drug-Coated Balloon Market Size, Share & Analysis | Global | 2020-2026 | MedCore | Segmented by: PTA Balloon Type (Standard, High-Pressure, Large, Small, Specialty) & Setting (Hospitals, Office-Based Labs) & DCBs by Segment (SFA, BTK, AV Access)

This global market research includes 0.014”-0.035” balloons, high-pressure balloons, large balloons greater than 12mm in diameter and specialty balloons. Specialty balloons include cryoplasty balloons, cutting balloons, scoring balloons and other balloons. The analysis also include DCBs used in the superficial femoral artery (SFA) and in AV access procedures.

more...

Inferior Vena Cava Filter and Retrieval Device Market Analysis | United States | 2020-2026 | MedCore

Inferior vena cava filters (IVCFs) prevent pulmonary embolism by intercepting a thrombus before it can enter the circulatory system of the lungs. In general, IVCFs are composed of a nest or lattice of wire collapsed around a catheter that is used to guide the filter. The filter is then expanded or deployed at the desired location, usually just below the junction of the inferior vena cava and the lowest renal vein.

more...

Embolic Protection Devices Market Analysis | United States | 2020-2026 | MedCore

Carotid stenting can be accompanied with plaque dislodgment and plaque emboli. Thus, the initial popularity of carotid stents was tainted as these artifacts caused an unacceptably high incidence rate of strokes. Since then, the industry has responded by manufacturing embolic protection devices (EPDs). These devices are used to capture dislodged vascular debris.

more...

Peripheral Chronic Total Occlusion (CTO) Devices Market Size, Share & Trends Analysis | Global | 2020-2026 | MedCore | Includes: Recanalization & Re-entry Devices

The global peripheral chronic total occlusion (CTO) device market is expected to increase over the forecast period to reach $258.2 million by 2026. This global market research on chronic total occlusion (CTO) devices spans over 70 countries and includes re-canalization and re-entry devices, considered jointly in the analysis.

more...

Atherectomy Device Market Analysis | United States | 2020-2026 | MedCore

Atherectomy is a procedure used for removing plaque deposits from arteries. They have traditionally been more effective in peripheral than coronary applications. The success of atherectomies has been driven by the limited performance of existing treatments. Often, a blockage is alleviated above the knee, only to have the blood flow deteriorate due to further bottlenecks below the knee. Failure to resolve these vascular limitations can result in critical limb ischemia, ulceration, limb pain or eventual amputation if left untreated.

more...

Atherectomy Devices Market Analysis | Europe | 2020-2026 | MedCore

Atherectomy is a procedure used for removing plaque deposits from arteries. They have traditionally been more effective in peripheral than coronary applications. The success of atherectomies has been driven by the limited performance of existing treatments. Often a blockage is alleviated above the knee, only to have the blood flow deteriorate due to further bottlenecks below the knee. Failure to resolve these vascular limitations can result in critical limb ischemia, ulceration, limb pain or eventual amputation, if left untreated.

more...

AV Access Thrombectomy Devices Market Analysis | Europe | 2020-2026 | MedCore

Lumen stenosis can occur due to the accumulation of thrombosis or plaque particles in a similar manner to peripheral arterial disease. The accumulation of these plaque particles has also been shown to cause calcification. Lumen stenosis is a considerable problem for both arteriovenous (AV) access surgical grafts and native fistulae because they have poor vessel patency. Due to their tendency to acquire blockages, AV access surgical grafts will require revascularization twice a year, and native fistulae will need to be cleared at least once a year.

more...

Chronic Total Occlusion Devices Market Analysis | Europe | 2020-2026 | MedCore

Chronic total occlusions (CTOs) are complete blockages of arteries. In the case of a hard plaque, over 50% of the occlusion could consist of calcified tissue. Soft plaques typically consist of cholesterol, macrophages and other cells.
The most common method to cross a CTO is to attempt to pass a guidewire through. In other cases, a specialty hydrophilic guidewire may be used. However, if these guidewire-based methods are not sufficient due to poor visualization and calcified heterogeneous lesions, specialized devices must come into play to enable the subsequent deployment of a stent, PTA balloon or even most atherectomy devices.

more...

Embolic Protection Devices Market Analysis | Europe | 2020-2026 | MedCore

Carotid stenting can be accompanied with plaque dislodgment and plaque emboli. Thus, the initial popularity of carotid stents were tainted as these artifacts caused an unacceptably high incidence rate of strokes. Since then, the industry has responded by manufacturing embolic protection devices (EPDs). These devices are used to capture dislodged vascular debris.
There are many different EPD platforms available for use in the peripheral vascular market, including filters, arterial occlusion balloons and devices that redirect blood flow.

more...